29.04.24 | Vollzeit | Planegg | Formycon AGIT Business Partner (gn) Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGIT Business Partner (gn) Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGIT Business Partner (gn) Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Planegg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Business Development in Planegg kostenlos abonnieren.